Recurrent somatic pathogenic KRAS mutations, including 25 cases of alterations at G12 and 1 case at Q61, were identified in 37.1% (26/70) of adenomyosis cases (Figs. 1c, f, g and Supplementary Data 12). The gene discussed is KRAS; the disease is adenomyosis.